Trial intelligence / Profile preview

Endobarrier Treatment on Fertility in Women With PCOS

NCT02255578Phase 3Unknown

Sponsor
Sheba Medical Center
Start
Sep 2014
Primary completion
Sep 2017
Countries
1
01

Overview

Phase 3, open-label trial in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Sheba Medical Center. Primary endpoint: Change in egg quality or ovulation rate after Endobarrier treatment at 2.5 years. Status: unknown.

02

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02255578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02255578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call